Amplia Therapeutics |
High $0.08 |
Low $0.07 |
Trades 8 |
Turnover $9,058 |
Volume 120,981 |
| 30 June 2023 at 2:59pm | ||||
|
Market Cap (16-Nov) $46,198,080 (1,444th) |
Close (30-Jun) $0.076 |
Volume (30-Jun) 120,981 |
Shortsold (9-Nov) 30,144 (0.01%) (594th) |
|
52w High $0.275 |
52w Low $0.076 |
P/E - |
EPS -0.02 |
Change of Director's Interest Notice - Dr. Warwick Tong
ATX released this announcement to the ASX on 4 August 2022, 12:17. The announcement is not marked as price sensitive, and is 3 page(s) in length and 345.52kb in size.
You can view all announcements from ATX and see how they appear on a price chart on the announcements page.
At the date of this announcement, ATX was 0.003% short sold according to ASIC data. It was ranked the 634th most shorted stock on the ASX. It is now ranked as the 594th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (09 November 2026).
| Other Recent Announcements from ATX | |
|---|---|
| AMP945 International Nonproprietary Name Narmafotinib | 21 June 2023, 8:34 |
| Amplia AGM to be held Thursday 24 August 2023 | 19 June 2023, 17:34 |
| Key to Corporate Governance Disclosures | 31 May 2023, 8:14 |
| Change of Director's Interest Notice - Dr. Warwick Tong | 4 August 2022, 12:17 |
| First Patient Recruited to ACCENT Trial in Pancreatic Cancer | 2 August 2022, 11:53 |
| Quarterly Activities and Cashflow Reports - June 2022 Qtr | 28 July 2022, 10:44 |
| Presentation at Major Pancreatic Cancer Conference | 25 July 2022, 9:24 |
If you were already registered, log in here.